SENOXY-CV 625 TABLETS

Amoxycillin 500 mg , Clavulinic acid 125 mg, Lactobacillus 60 millions Spored (FC)

Amoxycillin 500mg + Clavulanic Acid 125mg + Lactobacillus 60 Millions Spores Tablets

Brand Name

Senoxy-CV 625 Tablets

Senoxy-CV 625 Tablets is a prescription antibacterial combination containing amoxycillin, clavulanic acid and Lactobacillus. It is intended for the treatment of susceptible bacterial infections when prescribed by a qualified healthcare professional.

Packing

10 × 6 Strip Pack

The product is supplied in strip packaging designed to protect the tablets during storage, handling and transportation. Store the medicine according to the instructions provided on the product packaging.

Uses

This combination is used for the treatment of various bacterial infections. Amoxycillin is a penicillin-type antibiotic that works by interfering with the formation of the bacterial cell wall. Clavulanic acid is a beta-lactamase inhibitor. It helps protect amoxycillin from certain enzymes produced by resistant bacteria, thereby extending its antibacterial activity.

Lactobacillus is included to help support the balance of beneficial bacteria in the intestine, which may be disturbed during antibiotic treatment. Similar three-component products containing amoxycillin 500mg, clavulanic acid 125mg and Lactobacillus are described for the treatment of bacterial infections and for helping reduce digestive problems associated with antibiotic use.

The medicine may be prescribed for infections affecting areas such as the respiratory tract, ears, sinuses, urinary tract, skin and soft tissues, and dental infections, depending on the causative bacteria and clinical assessment. It does not treat viral infections such as the common cold or influenza.

Antibiotics should be used only when there is a suitable medical indication. The choice of treatment depends on the type and severity of infection, bacterial susceptibility, previous antibiotic use and the patient's individual medical history.

Dosage

The dosage should be decided by the doctor according to the patient's age, body weight, kidney function, severity of infection and the type of bacteria suspected or confirmed.

For adults and children weighing 40 kg or more, prescribing information for the 500mg/125mg amoxycillin-clavulanic acid combination commonly specifies one tablet twice daily for appropriate infections. In some circumstances, the doctor may select a different regimen depending on the infection and clinical requirements.

Senoxy-CV 625 Tablets should preferably be taken with a meal to reduce the possibility of stomach-related discomfort. The tablet should be swallowed whole with water and should not be crushed or chewed unless specifically advised by a healthcare professional.

Take the medicine at evenly spaced times as prescribed and complete the course recommended by your doctor, even if symptoms improve earlier. Stopping an antibiotic without medical advice may allow some bacteria to survive and may result in the infection returning.

Patients with reduced kidney function may require a dose adjustment. The dosage should therefore not be changed without medical advice. Prescribing information recommends specific adjustments for patients with reduced creatinine clearance.

If a dose is missed, take it when remembered unless it is nearly time for the next dose. Do not take two doses together to make up for a missed dose.

Indications

This combination may be prescribed for susceptible bacterial infections such as:

  • Respiratory tract infections
  • Pneumonia and selected lower respiratory tract infections
  • Sinus infections
  • Ear infections, including acute otitis media
  • Urinary tract infections
  • Skin and soft-tissue infections
  • Dental infections and dental abscesses
  • Certain bone and joint infections
  • Other bacterial infections where amoxycillin with clavulanic acid is considered appropriate

The exact indication should be determined by the treating healthcare professional. Antibiotic selection should take into account the likely or confirmed causative organism and its susceptibility.

Side Effects

Like other prescription medicines, this combination may cause side effects. Many are mild and may improve as the body adjusts to treatment.

Commonly reported effects may include:

  • Nausea
  • Vomiting
  • Diarrhoea
  • Indigestion
  • Abdominal discomfort
  • Headache
  • Dizziness
  • Skin rash
  • Itching
  • Hives
  • Vaginal or mucocutaneous candidiasis
  • Changes in taste
  • Tiredness

Diarrhoea, nausea and vomiting are among the commonly reported reactions with amoxycillin-clavulanic acid combinations. The Lactobacillus component is included in some formulations to help maintain intestinal bacterial balance during antibiotic treatment.

Serious Side Effects

Although uncommon, serious reactions can occur. Seek immediate medical attention if symptoms such as the following develop:

  • Severe allergic reaction
  • Swelling of the face, lips, tongue or throat
  • Difficulty breathing or swallowing
  • Severe skin rash, blistering or peeling
  • Persistent or severe diarrhoea, particularly if associated with blood
  • Yellowing of the skin or eyes
  • Dark urine
  • Severe abdominal pain
  • Unusual bleeding or bruising
  • Severe or persistent weakness

Patients who develop signs of a serious allergic reaction should receive urgent medical attention.

Contra Indications

This medicine should not be used in patients with a known allergy or hypersensitivity to amoxycillin, clavulanic acid, penicillins or other relevant beta-lactam antibiotics. It is also contraindicated in patients who have previously experienced a severe immediate allergic reaction to another beta-lactam antibiotic, such as certain cephalosporins, carbapenems or monobactams. A previous history of jaundice or liver impairment associated with amoxycillin-clavulanic acid is another important contraindication.

Before starting treatment, tell your doctor if you have kidney disease, liver disease, a history of antibiotic-related jaundice, glandular fever, blood disorders or previous allergic reactions to antibiotics.

Patients taking other medicines should also inform their doctor or pharmacist. Particular attention may be required with medicines such as anticoagulants, methotrexate, allopurinol and certain other prescription medicines.

Pregnant or breastfeeding women should consult their healthcare professional before taking this medicine.

Storage

Store Senoxy-CV 625 Tablets according to the storage conditions mentioned on the product packaging.

Keep the strips in their original packaging and protect the medicine from excessive heat, moisture and direct sunlight. A comparable three-component product containing the same antibacterial combination with Lactobacillus is listed with storage below 30°C; however, the specific storage instruction printed on the approved Senoxy-CV 625 packaging should be followed.

Keep the medicine out of reach of children. Do not use the tablets after the expiry date. Do not use the product if the strip is damaged or the tablets appear abnormal.

Unused or expired medicines should be disposed of according to appropriate local pharmaceutical disposal guidance.

PCD Pharma Franchise of Amoxycillin 500mg + Clavulanic Acid 125mg + Lactobacillus Tablets

Sentonssa Wellness Pvt. Ltd. offers pharmaceutical products for eligible distribution and PCD Pharma Franchise business requirements. Senoxy-CV 625 Tablets can be considered for suitable pharmaceutical marketing and distribution requirements, subject to applicable regulatory and commercial conditions. Sentonssa Wellness Pvt. Ltd. is positioned as a Amoxycillin 500mg + Clavulanic Acid 125mg + Lactobacillus Tablets Manufacturer and Exporter for pharmaceutical business requirements, with quality-focused manufacturing practices and WHO-GMP related standards. Businesses interested in this product can contact the company for product availability, territory requirements, commercial terms, distribution support and applicable documentation. All prescription antibacterial products should be promoted, supplied and distributed in accordance with applicable pharmaceutical laws and regulatory requirements.

Disclaimer

The information provided on this page is for educational and informational purposes and is intended for healthcare professionals, pharmacists, nurses, paramedical staff and other appropriate healthcare audiences.

Senoxy-CV 625 Tablets is a prescription medicine and should be used only under the supervision of a qualified healthcare professional. Do not self-medicate with antibiotics or change the prescribed dose or treatment duration without medical advice.

The information on this page does not replace professional medical advice, diagnosis or treatment and may not cover every possible precaution, interaction, contraindication or adverse reaction.

Product composition, Lactobacillus strength, indications, pack details, storage conditions and other product-specific information should be verified against the current approved product artwork, package information and applicable regulatory documentation before publication or use.